American Journal of Kidney Diseases
Volume 54, Issue 5 , Pages 795-797 , November 2009

Renal Denervation for Resistant Hypertension

  • Emmanuel L. Bravo, MD
    • ,
  • Mohammed A. Rafey, MD
    • ,
  • Joseph V. Nally Jr, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Joseph V. Nally Jr, MD, Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave-Q7, Cleveland, OH 44195

References 

  1. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52:818–827
  2. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510–e526
  3. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373(9671):1275–1281
  4. Smithwick RH, Thompson JE. Splanchnicectomy for essential hypertension: results in 1,266 cases. JAMA. 1953;1:403–408
  5. Hausberg M, Kosch M, Harmelink P, et al. Sympathetic nerve activity in end-stage renal disease. Circulation. 2002;106(15):1974–1979
  6. Joles JA, Koomans HA. Causes and consequences of increased sympathetic activity in renal disease. Hypertension. 2004;43(4):699–706
  7. Schlaich MP, Socratous F, Hennebry S, et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol. 2009;20(5):933–939
  8. DiBona GF. Neural control of the kidney: past, present, and future. Hypertension. 2003;41(3 pt 2):621–624
  9. Petersen JS, Kopp UC, DiBona GF. Neurogenic control of renal function. In:  Massry SG,  Glassock RJ editor. 3rd ed.. Textbook of Nephrology. vol. 1:Baltimore: Williams & Wilkins; 1995;p. 66–70
  10. Campese VM, Kogosov E, Koss M. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis. 1995;26:861–865
  11. Li G, Xu J, Wang P, et al. Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation. 2008;117:1277–1282
  12. Fujii T, Kurata H, Takaoka M, et al. The role of renal sympathetic nervous system in the pathogenesis of ischemic acute renal failure. Eur J Pharmacol. Nov 28 2003;481(2-3):241–248
  13. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis (Dutch Renal Artery Stenosis Intervention Cooperative Study Group). N Engl J Med. 2000;342(14):1007–1014
  14. Kalra PA, et al. Angioplasty and Stenting for Renal Artery Lesions (ASTRAL). Presented at the Society for Cardiovascular Angiography and Interventions (SCAI-ACCi2), March 29-April 1, 2008; Chicago, IL.

 Originally published online as doi: 10.1053/j.ajkd.2009.07.005 on September 9, 2009.

PII: S0272-6386(09)00977-9

doi: 10.1053/j.ajkd.2009.07.005

American Journal of Kidney Diseases
Volume 54, Issue 5 , Pages 795-797 , November 2009

Article Tools